|drug1521||Hydroxychloroquine 200 Mg Oral Tablet Wiki||0.71|
There is one clinical trial.
This study investigates the efficay and tolerance of 5-days course of hydroxychloroquine or hydroxychloroquine and azithromycin of patients with COVID-19 infection. The investigators will undertake a randomized, double-blind, controlled Trial in the region of Sousse Tunisia
Description: Clinical recovery is defined as a complete resolution clinical signs appeared during the medical history and related to COVID-19.Measure: Clinical recovery at day-14, from the start of treatment. Time: 14 days
Description: RT-PCR will be realized in same laboratoryMeasure: Viral Clearance via RT-PCR at day 5- 7-10 and day 14 Time: 5- 7-10 and day 14
Data processed on January 01, 2021.
An HTML report was created for each of the unique drugs, MeSH, and HPO terms associated with COVID-19 clinical trials. Each report contains a list of either the drug, the MeSH terms, or the HPO terms. All of the terms in a category are displayed on the left-hand side of the report to enable easy navigation, and the reports contain a list of correlated drugs, MeSH, and HPO terms. Further, all reports contain the details of the clinical trials in which the term is referenced. Every clinical trial report shows the mapped HPO and MeSH terms, which are also hyperlinked. Related HPO terms, with their associated genes, protein mutations, and SNPs are also referenced in the report.Drug Reports MeSH Reports HPO Reports